Welltower Past Earnings Performance
Past criteria checks 4/6
Welltower's earnings have been declining at an average annual rate of -31.7%, while the Health Care REITs industry saw earnings declining at 9.8% annually. Revenues have been growing at an average rate of 5.6% per year. Welltower's return on equity is 1.4%, and it has net margins of 5.1%.
Key information
-31.7%
Earnings growth rate
-34.9%
EPS growth rate
| Health Care REITs Industry Growth | -12.2% |
| Revenue growth rate | 5.6% |
| Return on equity | 1.4% |
| Net Margin | 5.1% |
| Next Earnings Update | 29 Apr 2024 |
Recent past performance updates
Recent updates
Welltower: High Quality Comes At A Full Price
Apr 09Why Avoid Welltower
Jan 22Hold Welltower Inc.: Premium REIT, But Expensive.
Dec 13Welltower: Set To Benefit From Aging Population
Sep 28Welltower Remains Highly Capital Efficient, Enhanced By Portfolio Scale Growth
Jul 18Welltower goes ex-dividend on Monday
Feb 24Welltower Q4 results largely in line, but 2023 outlook falls short of expectations
Feb 15Welltower drops 8% after new short report from Hindenburg Research
Dec 07Welltower FFO of $0.84 beats by $0.01, revenue of $1.47B beats by $10M
Nov 07Why Welltower Is A Beaten-Down Buy For Turbulent Times
Sep 30Welltower goes ex-dividend on Monday
Aug 19Welltower: Low Payer, High Debt, Merger Intrigue
Jul 21Welltower: Pricing In Chickens Before The Eggs Hatch
May 04Welltower: 2.6% Yield And Big Dividend Upside
Mar 24Welltower: Banking On Strong Future Growth Drivers And Financial Capabilities
Feb 28Welltower: The One Housing REIT To Own For The Long Term
Dec 23Revenue & Expenses BreakdownBeta
How Welltower makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 6,638 | 340 | 179 | 0 |
| 30 Sep 23 | 6,322 | 252 | 176 | 0 |
| 30 Jun 23 | 6,134 | 118 | 165 | 0 |
| 31 Mar 23 | 5,938 | 105 | 157 | 0 |
| 31 Dec 22 | 5,802 | 141 | 150 | 0 |
| 30 Sep 22 | 5,619 | 204 | 142 | 0 |
| 30 Jun 22 | 5,385 | 390 | 140 | 0 |
| 31 Mar 22 | 5,053 | 327 | 135 | 0 |
| 31 Dec 21 | 4,737 | 336 | 127 | 0 |
| 30 Sep 21 | 4,555 | 441 | 121 | 0 |
| 30 Jun 21 | 4,352 | 587 | 120 | 0 |
| 31 Mar 21 | 4,393 | 740 | 123 | 0 |
| 31 Dec 20 | 4,587 | 979 | 128 | 0 |
| 30 Sep 20 | 4,747 | 1,039 | 127 | 0 |
| 30 Jun 20 | 4,976 | 1,304 | 127 | 0 |
| 31 Mar 20 | 5,108 | 1,262 | 127 | 0 |
| 31 Dec 19 | 5,121 | 1,232 | 127 | 0 |
| 30 Sep 19 | 5,100 | 1,110 | 131 | 0 |
| 30 Jun 19 | 5,070 | 584 | 129 | 0 |
| 31 Mar 19 | 4,865 | 601 | 128 | 0 |
| 31 Dec 18 | 4,700 | 758 | 126 | 0 |
| 30 Sep 18 | 4,553 | 545 | 124 | 0 |
| 30 Jun 18 | 4,408 | 555 | 125 | 0 |
| 31 Mar 18 | 4,351 | 589 | 125 | 0 |
| 31 Dec 17 | 4,317 | 464 | 122 | 0 |
| 30 Sep 17 | 4,291 | 908 | 126 | 0 |
| 30 Jun 17 | 4,278 | 1,169 | 133 | 0 |
| 31 Mar 17 | 4,296 | 1,176 | 141 | 0 |
| 31 Dec 16 | 4,281 | 1,012 | 155 | 0 |
| 30 Sep 16 | 4,232 | 812 | 159 | 0 |
| 30 Jun 16 | 4,132 | 659 | 159 | 0 |
| 31 Mar 16 | 4,013 | 777 | 158 | 0 |
| 31 Dec 15 | 3,860 | 818 | 147 | 0 |
| 30 Sep 15 | 3,698 | 874 | 158 | 0 |
| 30 Jun 15 | 3,567 | 828 | 152 | 0 |
| 31 Mar 15 | 3,436 | 581 | 145 | 0 |
| 31 Dec 14 | 3,344 | 440 | 143 | 0 |
| 30 Sep 14 | 3,264 | 270 | 124 | 0 |
| 30 Jun 14 | 3,201 | 149 | 122 | 0 |
| 31 Mar 14 | 3,053 | 106 | 114 | 0 |
| 31 Dec 13 | 2,881 | 27 | 108 | 0 |
| 30 Sep 13 | 2,580 | 57 | 100 | 0 |
| 30 Jun 13 | 2,258 | 64 | 95 | 0 |
Quality Earnings: WELL has high quality earnings.
Growing Profit Margin: WELL's current net profit margins (5.1%) are higher than last year (2.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: WELL's earnings have declined by 31.7% per year over the past 5 years.
Accelerating Growth: WELL's earnings growth over the past year (140.8%) exceeds its 5-year average (-31.7% per year).
Earnings vs Industry: WELL earnings growth over the past year (140.8%) exceeded the Health Care REITs industry -18.7%.
Return on Equity
High ROE: WELL's Return on Equity (1.4%) is considered low.